Prediction Case File
YouTubeEvaluation Complete

Acurx Pharmaceuticals, Inc. Stock Prediction and Forecast [ACXP]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.us09 Oct 2025, 03:10 UTC
Video preview for Acurx Pharmaceuticals, Inc. Stock Prediction and Forecast [ACXP]
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis for ACXP stock shows it has broken through an upward trend. Pullbacks should find support at $7.68, potentially offering a buying opportunity. A fan theory suggests a peak at $11.55 acting as resistance. The stock has potential for a 175.88% increase over the next 3 months, with returns from 29.80% to 161.53%. The twelve month analysis indicates a projected 41.76% change, placing the future price between $2.14 and $11.48. The price increased by 88.81% closing the last trading day at $8.10. High volatility is noted, the weekly being 10.54%, and medium risk. There are several buy signals, and a strong buy candidate.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

StockInvest.us

Tracked signals
1521
Historical success
43.3%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.